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Abstract
Carbon nanotubes (CNTs), the product of new technology, may be used in a wide range of
applications. Because they present similarities to asbestos fibres in terms of their shape and size, it
is legitimate to raise the question of their safety for human health. Recent animal and cellular studies
suggest that CNTs elicit tissue and cell responses similar to those observed with asbestos fibres,
which increases concern about the adverse biological effects of CNTs. While asbestos fibres'
mechanisms of action are not fully understood, sufficient results are available to develop
hypotheses about the significant factors underlying their damaging effects. This review will
summarize the current state of knowledge about the biological effects of CNTs and will discuss to
what extent they present similarities to those of asbestos fibres. Finally, the characteristics of
asbestos known to be associated with toxicity will be analyzed to address the possible impact of
CNTs.
Introduction
Carbon nanotubes (CNTs) have unique chemical and
physical characteristics as a result of their nanostructure.
CNTs may be used in a wide range of applications, in
fields as diverse as electronics and medicine [1,2]. Due to
their widespread use, it is important to determine the
safety of CNTs for the protection of ecological systems and
human health. Research to investigate the biological
effects of CNTs is advancing today in order to foresee and
prevent their potentially harmful effects. CNTs have fibre-
like characteristics in terms of their elongated shape,
dimensions and aspect ratio. As particles with at least one
dimension of less than 100 nm, they correspond to High
Aspect Ratio Nanoparticles (HARN) [3]. In light of the
health impact of mineral fibres, especially the fibrogenic
and carcinogenic potency of asbestos fibres, and the
health and socio-economical tragedies caused by unregu-
lated asbestos utilization, the increasing development and
uses of CNTs have triggered concern about their potential
toxicity [4-8].
In recent years, several publications have reported the
effects of CNTs. Most studies have concerned animal and
cell responses, focusing primarily on respiratory diseases,
especially the inflammatory effects in the lung. However,
while inhalation is one important probable route of con-
tamination, it must be kept in mind that there are other
relevant routes of exposure. A severe primary cancer,
malignant mesothelioma (MM), has been closely linked
to asbestos exposure [9,10]. Epidemiological and animal
studies have shown that asbestos fibres are not the only
fibres to be associated with a risk of MM development.
Epidemiological studies have demonstrated a higher inci-
dence of MM in populations exposed to asbestiform and
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non-asbestos fibres [11-14]. Some manmade vitreous
fibres have caused MM in animal experiments [15]. The
question of whether CNTs might potentially be linked to
MM development justifies further research in this area.
Moreover, on the basis of the literature, CNTs have
already shown effects in animals and in cell systems that
are similar to those observed with asbestos fibres
[1,2,5,7]. Two recent studies showed the occurrence of
MM in genetically-modified cancer-sensitized mice and in
conventional Fischer 344 rats exposed to CNTs by intra-
peritoneal or intrascrotal administration respectively
[16,17]. These initial results underline the urgent need for
information to further our knowledge about CNTs' poten-
tial to cause MM.
MM is a primary tumour of the serosas caused by the neo-
plastic transformation of mesothelial cells. In populations
exposed to asbestos fibres, MM mainly occurs in the
pleura, and to a lesser extent in the peritoneum and peri-
cardium. MM is considered to be highly specific to asbes-
tos exposure, and is found in from 60% to over 80% of
cases [18-23]. In France, the calculated risk of MM attrib-
utable to occupational asbestos exposure was estimated at
83.2% (95% CI 76.8 to 89.6) in men, and 38.4% (95% CI
26.8 to 50.0) in women [24]. Many studies carried out to
investigate pleural and mesothelial cell response to asbes-
tos fibres have made it possible to reach sound hypotheses
about the mechanism of action of asbestos fibres in neo-
plastic mesothelial cell transformation.
The aim of the present review is to explore whether our
knowledge of the mechanism of action of asbestos fibres
could offer a useful paradigm to provide a warning or pre-
dict the risk of CNTs, to interpret data on animal and cel-
lular responses, and to evaluate their potential health
effects. For the purposes of our discussion, we consider
three points: (i) the fate of asbestos fibres following expo-
sure; (ii) their effects on mesothelial cells and the biolog-
ical mechanism associated with the cell response; (iii) the
nature of the fibre parameters involved in the harmful
effects, and their similarities with CNT characteristics. We
begin with a summary of current knowledge on the toxi-
cology of CNTs, then look at asbestos fibres' mechanisms
of action, focusing on carcinogenic effects at the pleural
level. Finally, we address the similarities between asbestos
and CNTs.
Toxicology of CNTs
Context of toxicological studies on CNT
Various kinds of CNTS have been the focus of toxicologi-
cal studies. CNTs are heterogeneous in terms of their
structure, impurities and physico-chemical properties.
Both single-walled (SWCNTs) and multi-walled (MWC-
NTs) CNTs have been examined in toxicological studies,
including commercial and laboratory-made CNTs,
whether purified or used as produced. The effects of CNTs
have been investigated following in vivo exposure of
rodents, and on several types of cells in culture. Most stud-
ies concerned pulmonary toxicity [1,2,5]. Animal experi-
ments mainly focused on inflammatory responses after
exposure by intratracheal instillation or aspiration, or
intraperitoneal injection. In vitro cell systems with several
types of mammalian cells have been used to study inflam-
matory responses and genotoxicity. A few in vivo and in
vitro studies were related to dermal toxicity, and some in
vitro studies focused on neurons [2]. Toxicity test systems
on procaryotes were also used to assess genotoxicity. Here
our focus will be on respiratory effects.
Biological effects of CNTs
Translocation
Biodistribution of CNTs after deposition in the lung or via
other routes has been poorly investigated. A translocation
of SWCNTs in various organs has been reported by several
authors [25-29]. In a recent study, MWCNTs deposited by
intratracheal instillation in rats revealed clearance due to
macrophage uptake and the lymphatic system without
evidence of crossing the pulmonary barrier, six months
after instillation [29]. It can be noted that macrophage
and lymphatic clearance was also demonstrated following
administration or exposure to asbestos fibres [30-33].
Erdely et al. [30] suggest that the release of soluble inflam-
matory factors could circulate to the vascular blood com-
partment after lung deposition of CNTs. The release of
circulating factors must be taken into consideration to
account for fibre effects. While asbestos fibres have been
detected in the pleura, soluble molecules could also
account for the pleural response [34], and genotoxicity
may be due to clastogenic factors [35,36]. Additional
studies are needed to determine the pharmacokinetics of
CNTs. Regarding the numerous varieties of CNTs associ-
ated with a broad scale of physical and physico-chemical
properties, fundamental studies will be necessary to estab-
lish the parameters leading the translocation process.
Biological effects on mesothelial cells
In vivo effects on mesothelial cells
Six recently-published studies concerned CNTs' effects on
mesothelial cells. Three reported findings from animal
experiments and three from cell system studies. One ani-
mal experiment concerned the mesothelial cell inflamma-
tory response and pathological changes after intra-
peritoneal injection [37]. The authors exposed C57Bl/6
mice to four samples of MWCNTs of different sizes and
aggregation states. There was one sample of "short" MWC-
NTs (from NanoLab, Inc; mean diameter: 14.8 ± 0.5 nm;
mean length: 1–5 μm); two samples of "long" MWCNTs
(Long1, from Mitsui & Co.; mean diameter: 84.9 ± 1.9
nm; mean length: 40–50 μm [24% > 15 μm of length];
Long2 from Univ. Manchester; mean diameter: 165 ± 4.7Particle and Fibre Toxicology 2009, 6:16 http://www.particleandfibretoxicology.com/content/6/1/16
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nm; mean length: 20–100 μm [84% > 15 μm of length]);
and one sample of more tangled MWCNTs (from
NanoLab, Inc.; mean diameter: 10.4 ± 0.3 nm; mean
length: 5–20 μm), as well as carbon black. At the same
time, two samples of amosite fibres were tested; these
were short fibres (4.5% > 15 μm of length) and long fibres
(50.4% > 15 μm of length) known to be differently path-
ogenic in rodents. In prior experiments, inhalation and
intraperitoneal exposure in rats to long amosite fibres
revealed greater pathogenicity than short fibres in terms of
fibrosis and cancer [38,39]. In the study reported by
Poland et al. [37], inflammation was assessed after injec-
tion of 50 μg of MWCNTs/mouse, after 24 h and seven
days. The end points were quantification of inflammation
in peritoneal lavage and histology of diaphragm. Only
long samples of MWCNTs and of amosite produced
inflammation and granulomas. Histological analyses
revealed the occurrence of "frustrated phagocytosis" by
macrophages. These results thus demonstrated some sim-
ilarities between the responses to the long forms of
amosite and MWCNTs. Several of the effects of asbestos
were also found with CNTs. There were higher inflamma-
tory responses with samples of long fibres. Only the sam-
ples that contained long fibres caused granulomas and
"frustrated phagocytosis".
A long-term study was performed by Takagi et al. [17] who
inoculated MWCNTs (MWCNTs-7 from Mitsui; diameter:
100 nm; length: 27% > 5 μm) in the peritoneal cavity of
C57Bl/6 p53+/- mice. Because these mice have a mutation
in one allele of the Trp53 gene, they are prone to develop
cancer. Crocidolite fibres were inoculated as positive con-
trol. Mesotheliomas were found after exposure to both
MWCNTs and crocidolite. This study has been discussed
on several points, including concern about the type of
mice, inappropriate exposure methods, high exposure
dose, underestimation of the number of particles of
MWCNTs and poorly-illustrated histology [40,41].
Details can be found in the different papers but some of
the authors' replies can be summarized here. It is recog-
nized that Trp53+/- mice are more prone to develop can-
cers, and that the response using high doses by the
intraperitoneal route of exposure provides different infor-
mation regarding hazard potency. However, spontaneous
excess of mesotheliomas has not been reported in this
type of mice, and the injection method is applicable to the
hazard approach for mesothelial cells in the absence of
human data. Concerning the dose, the authors mentioned
that other experiments using lower doses are in progress,
giving similar responses [40]. More recently, MWCNTs-7
were administered by a single intrascrotal injection in 7
Fischer 344 rats (240 μg/rat) maintained for an observa-
tion period of 52 weeks [16]. Dimensions were 82% of the
MWCNTs with a diameter between 70–110 nm, and
72.5% between 1–4 μm in length. Five vehicle-treated
controls and 7 UICC crocidolite-treated rats (470 μg/rat)
were also studied. The overall incidence of mesotheliomas
was 86% in MWCNT-treated rats while no mesothelioma
was found in vehicle- or crocidolite-treated rats. This
method of exposure of mesothelial cells is not usually
used to assess a carcinogenic potency of fibres. However,
injury at the scrotal mesothelium is used as a method to
investigate the repair mechanism of peritoneal mesothe-
lium [42,43]. Further data are clearly needed to improve
our knowledge of the effects of these MWCNTs on mes-
othelial cells in vivo.
Effects on mesothelial cells in vitro
To the best of our knowledge, four studies have reported
in vitro effects on mesothelial cells. DNA breakage and
DNA repair were found in both human normal and
malignant mesothelial cells exposed to SWCNTs, as well
as cell activation via AP-1, NF-κB and Akt [44]. Another
study concluded that there was alteration of cell viability
and decreased cell proliferation in human mesothelioma
cells exposed to SWCNTs [45]. Three studies reported
cytotoxicity on human normal mesothelial cells, malig-
nant mesothelioma cell line, and on largeTSV40-trans-
formed mesothelial cells (Met-5A) [44,46,47]. It is
noteworthy that the same raw CNT material with different
degrees of dispersion exerted different cytotoxicity on a
human mesothelioma cell line [47]. In this study, the tox-
icity of CNT-bundles (well-dispersed material with a bun-
dle diameter of around 20 nm) was less than that of CNT-
agglomerates (densely roped aggregates with a rope diam-
eter in the micron-range). CNTs appear to be taken up by
different cell types and diverse in vitro effects have been
associated with CNTs uptake [2,45]. However, the cellular
uptake of CNTs is controversial. Both absence and signif-
icant uptake have been reported, as recently discussed [1].
Uptake is likely dependent on interactions between cellu-
lar receptors and cell surface functions, and CNTs surface
reactivity. A variety of cell surface functions may be found,
depending on the cell type. CNTs may also carry diverse
reactive groups. Different sorts of chemicals and biologi-
cal molecules are currently used to disperse CNTs that
may modify the CNTs surface. Hence cell-CNT interac-
tions are dependent on a number of intrinsic and extrinsic
parameters. It should be recalled that modification of the
surface of asbestos fibres modulates the cell responses
[48-52]. In macrophages, the scavenger receptor with col-
lagenous structure (MARCO) seems to play an important
role in pulmonary damage induced by inorganic particles
[53] and may be involved in interaction between MWC-
NTs and plasma membrane of macrophages [54]. In mes-
othelial cells, integrin receptors were reported to interact
with asbestos fibres [50,55]. Recently, no particle internal-
isation was evidenced in largeTSV40-transformed mes-
othelial cells (MeT-5A) exposed to MWCNTs, despite
cytotoxicity [46]. Further studies are necessary to clarifyParticle and Fibre Toxicology 2009, 6:16 http://www.particleandfibretoxicology.com/content/6/1/16
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these controversial results, as fibre internalisation is an
important process accounting for the adverse cellular
effects of particles, and more data are needed to determine
the interactions of CNT with mesothelial cells.
Biological effects in other systems
Inflammation
Several studies have investigated the inflammatory
response provoked by CNT exposure, conducted on mice
or rats exposed via intratracheal instillation or inhalation.
Several reviews may be consulted for more details [1,2,4-8].
Some recent data are summarized in Table 1[30,56-59].
Regarding the large applications of CNTs and the known
adverse effects of fine particulate matter, the potential
effects of CNTs have also been investigated on systems
other than respiratory [1,2]. A recent study suggests that
deposition of both SWCNTs and MWCNTs produce a sys-
Table 1: Summary of recent in vivo experiments carried out with CNTs
Type of CNT System Summary results Reference
SWCNTs
(Carbon nanotech Inc. Tx).
Ø: 0.8–1.2 nm
L: 0.1–1 μm
Pharyngeal deposition in C57Bl/6 mice lung (40 
μg/mouse). Observation 4 hours post exposure.
Gene expression in lung and blood: 
Upregulation of genes involved in 
inflammation, oxidative stress, coagulation, 
tissue remodeling. Increased percentage of 
polymorphonuclear leucocytes (PMN) in 
blood and bronchoalveolar lavage (BAL).
[30]
SWCNTs.
240 nm 
(mode, aerodynamic diameter; in 
number)
Inhalation (4 days) in mice – 5 mg/m3
Short and mean term responses (1, 7, 28 days)
Lung analysis: Inflammation – Granulomas – 
Fibrosis – Mutation of K-ras
[58]
4.2 μm 
(mode, aerodynamic diameter; in 
mass)
Laryngeal deposition (10 μg/mouse).
Short and mean term responses (1, 7, 28 days)
Lung analysis: Inflammation – Granulomas – 
Fibrosis -
No mutation of K-ras. Lower effects 
compared to inhalation.
MWCNTs.
Ø: 40–60 nm
L:0.5–500 μm
Intratracheal deposition in rats.
One to 7 mg/kg. Short/mean term responses 
(1 to 90 days)
Inflammation; dose-dependent thickening of 
the alveolar lining
Particles still present after 3 months
[56]
MWCNTs grinded, unheated, 
heated to 600°C, 2400°C; 2400°C 
then grinded.
Ø: 20–50 nm
L: 0.7 ± 0.07 μm
Intratracheal deposition in rats, 2 mg/rat. Short-
term response (3 days); mean-term (60 days)
Inflammation (3 days). Granulomas (60 
days).
Effects of heated CNTs lower than 
unheated.
Grinding restored the effects.
[57]
MWCNTs.
Ø: 40–60 nm
L:0.5–500 μm
Intratracheal deposition in rats. One to 7 mg/kg. 
Short/mean term responses (1 to 90 days)
Inflammation; dose-dependent thickening of 
the alveolar lining
Particles still present after 3 months
[56]
MWCNTs
(Mitsui & Co., LDT)
Ø: ≅ 80 nm
L: 10–20 μm
Pharyngeal deposition in C57Bl/6 mice lung (40 
μg/mouse). Observation 4 hours post exposure.
Gene expression in lung and blood: 
Upregulation of genes involved in 
inflammation, oxidative stress, coagulation, 
tissue remodeling. Increased percentage of 
polymorphonuclear leucocytes (PMN) in 
blood and bronchoalveolar lavage (BAL).
[30]
MWCNTs
Shenzhen nanotech
Ø: 500 nm;
L: 10 μm
Inhalation (≈ 32 mg/m3) in mice for 5, 10, 15 days; 
deposition ≈ 0.07, 0.14; 0.24 μg/mouse. Short-
term response (8, 16, 24 days)
Small aggregates entering the alveolar wall
Cell proliferation and thickening of alveolar 
walls
[59]
Tracheal deposition: 50 μg/mouse Eight and 16 days: clumps deposited on 
lining wall of bronchi, no inflammation – 24 
days: inflammation.
Clumps in the alveoli destruction of alveolar 
structureParticle and Fibre Toxicology 2009, 6:16 http://www.particleandfibretoxicology.com/content/6/1/16
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temic response, which may affect the cardiovascular sys-
tem [30].
Genotoxicity
Both in vivo and in vitro effects of CNTs suggest a possible
genotoxic effect, related to inflammatory responses and
production of reactive oxygen species, as persistent
inflammation is considered to increase the carcinogenic
risk [60].
In vivo, a mutation of the K-ras oncogene was observed in
mice exposed to SWCNTs by inhalation, and chromo-
somal aberrations were detected in type II pneumocytes
after intratracheal deposition of MWCNTs in mice
[58,61]. Several in vitro studies have reported a genotoxic
potency using different cell types (Table 2)
[44,46,54,57,61-70]. Activation of DNA repair processes
and mutagenesis of the adenine phosphoribosyl trans-
ferase gene was found in mouse embryonic stem cells
[69]. Genotoxicity as assessed by the cytokinesis-block
micronucleus test, was found in rat lung epithelial cells
exposed to MWCNTs [57]. Micronuclei formation
occurred in human epithelial cells (MCF-7) treated with
MWCNTs, and a pancentrometric probe analysis demon-
strated both chromosome breakage and chromosome loss
[61]. DNA damage was also reported in SWCNT-treated
mouse embryo fibroblasts and in CNT-treated bronchial
epithelial BEAS 2B cells [63,67]. No mutation or DNA
breakage was found in a FE1-Mutatrade markMouse lung
epithelial cell line exposed to SWCNTs but purine oxida-
tion was detected with the Comet assay [71].
Investigations of the mutagenic potency of MWCNTs
using bacterial test systems did not reveal mutagenic activ-
ity [72,73]. These bacterial assays may not be fully rele-
vant to evaluate genotoxicity of particles. Previous results
with bacterial cells were generally not or only moderately
positive with asbestos fibres [74].
Asbestos fibres' mechanism of action
The asbestos legacy
Numerous publications on the mechanism of action of
asbestos fibres have emphasized several responses associ-
ated with the mechanism of toxicity at the serosal level.
They make it clear that two aspects must be considered:
the biological response and the particle status. The first
depends on several factors that include the fate of asbestos
fibres following inhalation, i.e., their ability to reach the
pleura. It is well know that deposition, clearance and
translocation of fibres are dependent on biological mech-
anisms and partners (mucociliary transport, phagocytic
cells), but also on fibre parameters, especially fibre
dimensions. Short fibres are more easily internalised by
macrophages than long fibres, and long fibres possibly
involve "frustrated phagocytosis." The biopersistence of
fibres is linked to both their dimensions and stability in
the biological milieu.
Fate of asbestos fibres
Regarding industrial uses and commercial applications of
asbestos fibres, the main risk of contamination is linked
to the inhalation route. In general, particle deposition
depends on aerodynamic considerations. Several authors
have studied the mechanism of fibre deposition and
retention in the lungs [75-78]. Once deposited in the
lung, asbestos fibres may be translocated into different
organs and tissues, including the pleura. This was demon-
strated in animals following inhalation or intratracheal
deposition [79], and in humans by investigation of fibre
retention in different body compartments including the
pleura [80-82]. A recent paper discusses the translocation
pathways of asbestos fibres to the pleura [83]. Transloca-
tion appears to be due to trans-cell migration and lym-
phatic circulation. These authors propose that fibres
deposited in the alveolar space can be translocated to the
interstitium, down the gradient of physiological water
absorption. This transfer is facilitated when the epithelial
layer is damaged. Once in the interstitium, fibres can be
distributed to different organs. Fibres can be cleared from
the interstitium via the lymphatic system and enter the
capillaries as inflammation increases the interstitial pres-
sure, allowing the fibres to migrate and be distributed
throughout the whole body. Therefore, fibres can reach
the pleura via the capillary system and transfer through
the visceral pleura. The parietal pleural has pores of rela-
tively large diameter (about 150–200 nm), and the pleu-
ral fluid drainage goes through stomatas where particles
are found to be concentrated.
Translocation of CNTs to the pleura can be assumed, as
asbestos fibres are not the only particles to be translocated
to this site. Migration was observed after inhalation of
refractory ceramic fibres and NMVF10a fibreglass in ham-
sters and rats, and anthracotic areas ("black spots") con-
taining particulate matter are present in human pleura
[81,84-87]. One important point for the study of CNT tox-
icity is therefore to determine their ability to be distrib-
uted in the body and to reach the pleura. It is likely that
the CNT aggregation state will modulate the rate of trans-
location. Recent experiments comparing inhalation and
tracheal or pharyngeal deposition of CNTs concluded that
the different effects were likely related to a difference in
the dispersion and aggregation state of the CNTs [58,59].
It can also be assumed that the CNT pre-treatments used
for particle dispersion will also influence the biodistribu-
tion of these particles. Moreover, it must be kept in mind
that CNT exposure takes place via routes other than inha-
lation, which ought to be investigated.Particle and Fibre Toxicology 2009, 6:16 http://www.particleandfibretoxicology.com/content/6/1/16
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Table 2: Summary of recent in vitro experiments carried out with CNTs
Type of CNT System Summary results Reference
SWCNTs (HiPco), (CNI Inc.).
Ø: 0.4–1.2 nm
L: 1–3 μm
Lung hamster fibroblasts (V79) Cytotoxicity (time and dose dependent)
DNA breakage (comet assay)
No significant enhancement of micronuclei
[62]
SWCNTs (50% SWCNT, about 40% 
other nanotubes).
Ø: 1.1 nm, L: 0.5–100 μm
BEAS 2B human bronchial epithelial 
cells
Dose-dependent decrease in cell viability. Dose-
dependent DNA damage. No formation of 
micronuclei
[63]
SWCNTs (NIST)
Ø: 1.4 nm, L:2–5 μm
Normal human mesothelial cells and 
human mesothelioma cell line
Cell death. DNA lesions
Stress response activation
[44]
SWCNTs. Folate conjugated.
Ø: 1–3 nm, L: 100 – 200 nm
HepG2 cells (express folate receptor) No toxicity if < 50 μg/ml. Dose-dependent 
apoptosis. Kinetics of SWCNT internalisation: Mb → 
cytoplasm → extracellular
[64]
SWCNTs (HiPco) Human lung epithelial cells A549 and 
immortalised NHBE
Decreased inflammatory response in TNF alpha-
stimulated cells
[65]
SWCNTs Mitsui & Co., Ltd
Size unspecified
Human aortic endothelial cells Internalisation: CNTs identified in the cytoplasm. 
Cytotoxicity. IL-8 release. Actin filament and 
Ecadherin disruption. Reduced tubule formation.
[66]
SWCNTs Mouse embryo fibroblasts Low cytotoxicity. DNA damage (comet assay)
Oxidative stress
[67]
MWCNTs.
Ø: 67 nm
Mouse macrophages (J774.1). No MAPKs activation; no apoptosis.
Interaction with membrane receptors (MARCO) and 
plasma membrane destruction
[54]
MWCNTs.
Ø:11.3 nm
L:0.7 μm
Human epithelial cells (MCF-7) Chromosomal aberrations (micronuclei) showing 
chromosome breakage and loss of whole 
chromosomes
[61]
MWCNTs (C100, Arkema).
Ø: 12 nm,
L: 0.1–13 μm
Human epithelial (A549) and Large T 
SV40 transformed mesothelial (Met-
5A) cells
Decrease in cell viability (mitochondrial alteration) 
without apoptosis. No oxidative stress. No 
MWCNT internalisation
[46]
MWCNTs grinded, unheated, heated 
to 600°C, 2400°C; 2400°C then 
grinded.
Ø: 20–50 nm; L: 0.7 ± 0.07 μm
Rat lung epithelial cells. Chromosomal aberrations (micronuclei)
Lower effects with 2400°C sample in comparison to 
600°C and unheated
[57]
MWCNTs.
Ø: 100–200 nm, L:a few μm
Human epithelial cells (A549) DNA breakage (comets).
No oxidative DNA lesions
[68]
MWCNTs
(Tsinghua & Nananfeng, Cine)
Mouse embryonic cells (ES) P53 activation. Induction of DNA repair.
Mutations (adenine phosphoribosyl transferase)
[69]
MWCNTs Mitsui & Co., Ltd
Size unspecified
Human aortic endothelial cells Cytotoxicity. IL-8 release. Actin filament and 
Ecadherin disruption. Reduced tubule formation.
[66]
MWCNTs Human pneumocytes A549 Decrease in cell viability
Internalisation
[70]Particle and Fibre Toxicology 2009, 6:16 http://www.particleandfibretoxicology.com/content/6/1/16
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Biological and genomic effects of asbestos fibres on 
mesothelial cells
Inflammation and mesothelial cell activation
Many authors have described the inflammatory processes
occurring in the lung and in the pleura, and shown that
fibres can interact with mesothelial cells in culture condi-
tions. Fibre deposition in the lung is followed by the
recruitment of inflammatory cells, which produce several
factors: ROS (reactive oxygen species), RNS (reactive
nitrogen species), clastogenic factors and cytokines that
may stimulate and/or damage neighbouring mesothelial
cells. Fibres also may produce ROS. Moreover, mesothe-
lial cells respond by fibre internalisation according to a
phagocytic process associated with oxidative reactions
[34,88-93].
In this situation, mesothelial cells adapt to the oxidative
environment by oxidative stress, increasing oxidant
defences and decreasing natural ROS and RNS produc-
tion. At the same time, several regulatory pathways are
activated: signalling pathways (MAPKs) associated with
cell proliferation and apoptosis, and DNA repair and con-
trol of cell cycle progression in response to DNA damage
[94,95]. These different reactions are the consequence of
2 types of interactions: between cells (inflammatory cells/
mesothelial cells) and between cells and fibres. As neo-
plastic transformation is linked to genetic damage and
requires proliferation steps, comparison between the gen-
otoxic effects of asbestos and CNTs might provide clues
making it possible to develop hypotheses about the
potential effects of CNTs.
Genotoxicity
Many investigations have focused on DNA damage pro-
voked by asbestos fibres in mesothelial cells. Several stud-
ies have demonstrated different types of DNA damage
(DNA breakage, base oxidation), and perturbation of the
mitotic process [94,95], showing that base oxidation and
DNA breakage (single strand and double strand breaks)
were detected in asbestos-treated mesothelial cells [95-
100]. These may be due to ROS/RNS production and to
the mesothelial cells' ability to phagocytise asbestos
fibres. Fibre uptake does not abolish the mitotic process as
some fibres are found in dividing mesothelial cells. More-
over, extensive chromosome damage was described. A list
of chromosome abnormalities has been reported by dif-
ferent authors. Asbestos fibres produce structural chromo-
some alterations; significant enhancement of aneuploid
cells, abnormal anaphases and telophases [101-105].
Induction of micronuclei by all types of asbestos in pri-
mary cultures of human mesothelial cells has been
reported by Poser et al. [106]. Other studies have shown
genomic alterations in asbestos-treated human mesothe-
lial cells. Loss of heterozygosity was detected as asbestos-
induced mutations in a human mesothelioma cell line
[107]. Using 3D reconstruction, Cortez et al. recently
reported mitotic abnormalities, centrosome amplification
and aneuploid cell formation in lung carcinoma cells,
even with long periods of recovery post-treatment [108].
These findings are similar to earlier reports concerning rat
pleural mesothelial cells and using less powerful meth-
ods.
Gene expression in asbestos-treated mesothelial cells
A few studies have investigated gene expression in asbes-
tos-treated mesothelial cells using microarray analysis
(Table 3) [109-111]. They confirmed results obtained in
studies focusing on given types of damages. Modulation
of several biological processes were observed. They were
associated with inflammatory, proliferation, DNA repair
and cell adhesion pathways. Further studies comparing
the cell response to CNTs and to the different types of
asbestos fibres are likely to be informative in order to
approach the possible effects of CNTs.
Gene alterations in mesothelioma
Epidemiological studies have shown that MM is a conse-
quence of asbestos exposure in a majority of cases [18-24].
This led us to assume that genomic alterations found in
MM could be linked to the effect of asbestos fibres. The
Table 3: Summary of in vitro experiments related to gene expression in crocidolite-treated mesothelial cells
System Summary results Reference
Human mesothelial cells (LP9/TERT-1) exposed to low and high 
concentrations (15 and 75 μm2/cm2 per dish) for 8 or 24 h
Oligonucleotide microarray analysis
ATF3-dependent modulation of inflammatory cytokines and 
growth factor production
[109]
Human SV40-immortalized pleural mesothelial (MeT-5A) cells 
exposed to 1 μg/cm2 dish for 1–48 h
Oligonucleotide microarray analysis
1 h: upregulation of nucleosome assembly, translational initiation, 
transcription, I-kappaB kinase/NF-kappaB cascade, survival
48 h: downregulation of cytoskeletal anchoring, transcription, 
survival
[110]
Normal rat pleural mesothelial cells exposed to 5 μg/cm2 dish for 
24 h
Oligonucleotide microarray analysis
Induction of fra-1-linked cd44 and c-met expression [111]Particle and Fibre Toxicology 2009, 6:16 http://www.particleandfibretoxicology.com/content/6/1/16
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identification of these changes can provide insight into
the molecular mechanism of action of asbestos on mes-
othelial cells. MM cells exhibit frequent alterations in
tumour suppressor genes found at the INK4 locus, and
often the type of alteration is deletions. NF2 is another fre-
quently inactivated tumour suppressor gene in MM cells.
Germinal mutations in NF2  are responsible for type 2
neurofibromatosis, but NF2 patients are not prone to
develop mesothelioma. TP53 is mutated less often in MM
cells.
To investigate whether genetic alterations in mesotheli-
oma might be relevant to the effect of asbestos fibres, ani-
mal models of human MM are developed. Mesotheliomas
develop following exposure, by intraperitoneal injection,
of hemizygous NF2  mice to asbestos fibres [112,113].
This made it possible to compare characteristics of mouse
and human mesotheliomas.
Histologically, very similar tumours were observed, and
the genomic alterations in the tumour suppressor genes
investigated were very close to those observed in human
MM. These gene are involved in the control of cell cycle
and junction stability. Regarding the function of the gene,
it might be of interest to determine the consequences of
CNT exposure on cell cycle progression and cell architec-
ture.
Asbestos fibre characteristics related to disease
If one looks at fibre parameters, several features appear to
be shared by CNTs and asbestos fibres. To compare CNTs
and asbestos fibres in relation to toxic potential, we
should focus on the asbestos characteristics modulating
asbestos toxicity. Shape, size, chemistry and surface reac-
tivity are all related to cell and tissue responses to asbestos
fibres.
Shape
CNTs have a thin and elongated shape compatible with a
fibre, according to the WHO fibre definition of a particle
with parallel edges and an aspect ratio (length/diameter)
greater than three. It seems that CNTs are prone to form
aggregates, ropes and clumps, a feature that is not fully
similar to asbestos, which forms bundles of rather well-
organized structures. The length of CNTs may vary, reach-
ing up to several micrometers or longer [7,114]. Accord-
ingly, "frustrated phagocytosis" was observed in cells
engulfing long CNTs [37].
Size
The diameters of asbestos fibres fall in the nanosize range.
If one refers to the dimensions of the UICC samples,
which have been used in a number of animal and cell
studies, the diameter of chrysotile fibres was less than
about 100 nm, and 200 nm for crocidolite. Length
depended on the sample, but generally averaged several
micrometers. However, there was a significant range in
length and a small percentage of fibres longer than 10 μm
were generally present.
Chemistry
Metals are considered to be important elements to
account for fibre toxicity. Iron content, either structural or
as contaminant, may be linked to the formation of ROS
and RNS. Depending on the method of production, CNTs
may contain metals as contaminants; moreover, they can
be functionalized to acquire specific properties. Data in
the literature show a wide qualitative and quantitative
diversity of metal contaminants in the chemical composi-
tion of CNT samples, emphasizing the importance of
using well-defined samples for toxicological analyses [7].
Surface reactivity
Surface reactivity is an important parameter in asbestos-
related effects. The production of ROS and RNS was men-
tioned above. It is interesting to note that some studies
indicate that, in contrast to asbestos, CNTs quench ROS in
an acellular system generating hydroxyl radicals [115].
While asbestos fibres are hydrophilic, CNTs, unless func-
tionalized, are hydrophobic. As a result, CNTs are often
treated with dispersing agents prior to exposing cells or
animals to CNTs suspended in aqueous medium.
Asbestos fibres' ability to adsorb biological molecules is
another fibre parameter to take into consideration. Asbes-
tos adsorbs proteins and phospholipids, which has conse-
quences on cell-fibre interactions. An enhancement of
biological effects can be observed (particle internalisa-
tion, cytotoxicity), as well as a reduction of toxicity [116-
119].
Asbestos bodies are structures found in the lung of asbes-
tos-exposed subjects. They consist of an asbestos fibre core
surrounded by a complex coat produced by the cell and
tissue reaction; they are made of apatite mineralization
and protein aggregation (hemosiderin, ferritin). These
structures are more likely formed on amphiboles rather
than on chrysotile. They are not specific to asbestos, as
they have been reported in other fibrous and non-fibrous
particles. It would be of interest to know whether these
structures could be formed on CNTs [120-122].
Biopersistence
While biopersistence is not an intrinsic particle parameter,
it has received attention for the evaluation of the carcino-
genic potency of manmade vitreous fibres (MMVFs)
[123,124]. Biopersistence in the lung is the result of a
clearance mechanism and the behaviour of fibres in the
biological medium. Clearance depends on particle uptake
by scavenger cells; it is then modulated by the fibre sizeParticle and Fibre Toxicology 2009, 6:16 http://www.particleandfibretoxicology.com/content/6/1/16
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and toxicity (short particles are eliminated following
uptake by macrophages; cytotoxic particles impair the
process). The behaviour of the fibres is also size-depend-
ent (fibre dimensions govern the mechanism and site of
deposition in the lung), as well as dependent on the fibre
structure and chemistry (these parameters modulate the
stability of the particles in the biological medium). Some
chemical elements may dissolve and reduce fibre strength,
breaking the fibres into smaller fragments. Finally, biop-
ersistence modulates the amount of fibre retained in the
lung and the time it remains in the lung. To date, CNTs
have been considered biopersistent, but further studies are
needed to determine the relevance of this parameter in the
context of human exposure to CNTs [57].
Discussion
CNTs are valuable industrial products with multiple
applications in the field of nanotechnologies, yet legiti-
mate concerns about their potential adverse effects on
human health need to be addressed. The risk of MM, a pri-
mary pleural carcinoma linked to asbestos exposure, must
be examined in light of the physical nature of CNTs,
which are elongated and ultrafine, and the fact that
human beings may be exposed to CNTs through inhala-
tion. While not yet definitive, data are now available pro-
viding information on the pulmonary and cellular effects
of CNTs, which may be compared to those of asbestos
fibres. Moreover, the asbestos fibre characteristics
involved in the toxic processes may be compared to those
of CNTs to determine their similarities. These compari-
sons make it possible to develop hypotheses about com-
mon and different mechanisms of action. A summary of
comparisons between CNTs and asbestos is provided in
Tables 4 and 5.
A paradigm for the health effects of HARN has emerged
from toxicology studies of industrial fibres, including
asbestos. A recent report reviewed state-of-the-art knowl-
edge of the toxicity of asbestos and HARN [3]. This clearly
suggest a community of toxicological features and con-
cern between HARN of different origin and composition.
The reader will find in this quoted review additional infor-
mation on other HARN (nanowires, nanorods) and the
proposal for a research strategy to determine the potential
toxicity of HARN.
Shape, structure and chemistry
Both CNTs and asbestos particles share fibrous morphol-
ogy, and their dimensions are in the same range. CNTs are
manufactured in two main forms, SWCNTs and MWC-
NTs. A SWCNT is a single-layer graphene sheet rolled up
in a cylindrical shape, whereas a MWCNT contains several
layers [125]. The structure of chrysotile presents similari-
ties with MWCNT. CNT samples may have much higher
length than asbestos fibrils and form clumps resulting in
different presentation and tissue penetration. One role of
CNT sample dispersion to modulate biological effects is
suggested by the results reported from in vivo experiments
studying inhalation and intratracheal deposition.
Biodistribution
Similarly to asbestos fibres, CNTs may be deposited and
retained in the lung after inhalation. So far, there is no
definitive data on their migration and long-term reten-
tion, and on their translocation to the pleura. Interaction
with mesothelial cells is likely important to account for
asbestos pathogenicity; however, distant effects after dep-
osition in the lung have been reported. As already men-
tioned, CNTs are the subject of scientific interest for a
large number of already mature or potential applications.
One paradox is that biological studies with CNTs are
designed to investigate both adverse (exposure to toxic
dust) and beneficial (nanomedicine) effects. These differ-
ent types of studies show that MWCNTs are concentrated
in the lymph nodes after deposition in the lung, and that
functionalized MWCNTs also accumulate in lymph nodes
after subcutaneous injection [29,126]. CNT biodistribu-
tion has been studied following intraperitoneal or intrave-
nous injection in mice. CNTs are distributed throughout
the entire body and cleared via urine excretion. McDevitt
et al. found an accumulation of labelled SWCNTs in the
kidney, liver, spleen and, to a lesser extent, in bone [127].
Table 4: Comparison between physical and chemical parameters of asbestos and CNTs
Parameter Comparison
Shape Both are elongated particles; fibre shaped.
Dimensions Asbestos fibre diameter: range of 100 nm. Chrysotile fibrils: ≅ 50 nm of diameter. Same order as MWCNTs.
Structure Chrysotile: multi-layered rolled sheets of brucite (MgOH2) and silicon oxide (SiO2). Important aggregation with CNTs, which 
may form more entangled bundles, ropes, than asbestos.
Chemistry Different chemistry. Possibility of metal impurities in both asbestos and CNTs.
Surface reactivity Both show sorptive properties to biological molecules. ROS production: no definitive answer for CNTs.Particle and Fibre Toxicology 2009, 6:16 http://www.particleandfibretoxicology.com/content/6/1/16
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There is to date no reason to exclude the possibility of
CNT translocation to the serosa.
In a recent paper, Hankin et al. [128] summarized the
research required into the mechanism of translocation of
nanoparticles across the respiratory epithelium, and the
resulting possible effects in and beyond the lung. The
authors provide recommendations to develop research on
translocation and penetration of nanoparticles that take
into consideration the parameters allowing a robust inter-
pretation of the data.
The relationship between structure and biological effects
Based on our present knowledge, a comparison between
cell responses to SWCNTs and MWCNTs cannot be estab-
lished. This is partly due to the limited number of investi-
gations carried out with both types of nanotubes in the
same assays. Nevertheless, both types are able to induce
biological responses in one or several cell types, and in the
lung. While studying the biodistribution of MWCNTs fol-
lowing intraperitoneal injection, Guo et al. compared dif-
ferent results obtained with both SWCNTs and MWCNTs
[129]. These authors suggest that toxic responses observed
in the kidney in some studies may depend on whether
CNTs are functionalized, a procedure that may improve
the biocompatibility.
Surface functionalization, purity and treatment of CNTs
appear to modulate the biological response, as found in
different studies [115,130,131]. The surface modifica-
tions of CNTs developed in the field of nanomedicine
studies are of interest to learn about interactions between
CNTs and cells or organelles. It is already known that sur-
face changes influences cell responses. Viability of neu-
roblastoma cells was not affected by pure MWCNTs (99%
purity). Viability and proliferation were reduced after acid
treatment or when MWCNTs of lower purity were used
(97%) [131]. Acute pulmonary toxicity and genotoxicity
of MWCNTs were reduced upon heating but restored
upon grinding, in relation with surface defects[57]
Studies carried out with asbestos have demonstrated that
long and thin fibres are more toxic than short fibres, with-
out excluding potential toxicity for short fibres. Limits of
4 μm or 8 μm in length have been proposed, mainly based
on in vivo experiments. CNTs can fulfil these length crite-
ria, and similarly to asbestos, long CNTs were more active
than short CNTs [37]. More data on size-dependent bio-
logical effects of CNTs will be of great interest.
Surface reactivity of asbestos fibres has been largely
advanced as a key parameter accounting for their toxicity
in terms of ROS production and sorptive abilities. ROS
production is associated with cytotoxicity, cell activation,
and chromosome and DNA damage. Conflicting data are
found with CNTs, as both production and scavenging of
ROS were described. CNTs are a large family regarding
their method of generation, treatment and functionaliza-
tion. Hence the surface reactivity of CNTs towards biolog-
ical systems will be largely dependent on the type of
nanotubes. This may be maximized by treatments to dis-
perse CNTs prior to use for biological studies. Different
CNTs samples may have more heterogeneous surface
activities than asbestos.
Biological effects
Available data in the literature concerning the effects of
CNTs on mesothelial cells remain limited. Several effects
of asbestos fibres, especially genetic damage, are related to
fibre internalisation. While asbestos fibres are clearly
internalized by mesothelial cells, there is no definitive
data on CNT uptake by these cells. The physico-chemical
Table 5: Comparison between biological effects of asbestos and CNTs
Cell/tissue response Comparison
Particle uptake Demonstrated with both types. Conflicting results with CNTs. Exocytosis found with CNTs, so far not 
investigated with asbestos.
Cytotoxicity Both cytotoxic.
DNA damage, mutation, gene interaction Found with both asbestos and CNTs.
Transfection Gene transfer is with asbestos. CNT gene knockdown.
Biodistribution Both types are cleared via the lymphatic system and found in different organs
Inflammation, granulomas, fibrosis Found with both asbestos and CNTs. Both types show dependence of biological effects with fibre 
dimensions: bioactivity of long fibres.
Cancer MM found with both asbestos and CNTs by peritoneal exposure.Particle and Fibre Toxicology 2009, 6:16 http://www.particleandfibretoxicology.com/content/6/1/16
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properties of CNTs are likely to take into consideration in
the occurrence of this physiological process.
Animals and cell systems exposed to CNTs appear to
develop several responses similar to those observed with
asbestos. There is some evidence that CNTs produce
inflammation and mesothelioma when inoculated in the
peritoneal cavity of mice. This result is consistent with
inflammatory potency after inhalation or intratracheal
instillation. Several CNT-exposed mammalian cells
respond in culture conditions by inflammatory reactions
and oxidative stress. Genotoxic potency has been reported
in different cell types, including mesothelial cells, as well
as in studies conducted in vivo. Hence CNTs used in exper-
imental systems fulfil several criteria to elicit tissue injury,
including the mesothelium.
Conclusion
The link between asbestos effects and mesothelioma has
been attributed to several mechanisms. This link has been
investigated using different animal models and cell types,
and substantial similarities exist in the responses of the
different cell types. Several fibre properties have been
linked to adverse effects. Shape, dimension and surface
reactivity are all important parameters. Reactive species
may produce DNA lesions (base oxidation, breaks); their
origin is related both to fibre surface reactivity and phago-
cytosis. Inflammation contributes to the production of
ROS/RNS. Chromosome damage appears to be of major
importance to account for the significant effects of asbes-
tos. Gene deletions and recombinations might result from
these effects. Integrity of some cell processes may be criti-
cal in the response to asbestos: dynamics of the cell mem-
brane (fibre uptake, cell division) and control of cell
division (check points, chromosome segregation proc-
esses, repair of DNA breakage, cytokinesis). In view of
findings of a much less hazard of short than some long/
non-biopersistent HARN, more information is needed on
the CNTs' characteristics and conditions to which we may
be exposed. Based on available data in the literature and
knowledge of the mechanisms of action of asbestos fibres,
it appears that CNTs may elicit responses that are similar
to those caused by asbestos fibres.
In this review, for the sake of brevity, CNTs have been con-
sidered as a single entity. However, there is a large degree
of heterogeneity within the CNT family. The legacy of our
knowledge on the mechanism of action of asbestos
prompts us to recognize some similarities between these
two types of particles. Nevertheless, in view of the diverse
uses of CNTs, toxicological studies should be carried out
in the context of the respective applications, taking into
consideration the possible interactions between the target
tissue and the nanotubes, and their possible biodistribu-
tion. An evaluation of the conditions and type of exposure
to CNTs thus appears mandatory to focus clearly on the
safety and health issues. Exposure by inhalation for aero-
solized CNTs must take into consideration both lung and
pleural diseases.
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